申请人:Angiochem Inc.
公开号:US20160015823A1
公开(公告)日:2016-01-21
The invention relates to dendrimers conjugated to multiple targeting peptides and one or more therapeutic, diagnostic, or imaging agents for delivery of such agents across the blood-brain barrier and into certain cell types including, cells expressing the LRP-1 receptor. Also described are methods of making compounds that comprise dendrimers conjugated to targeting peptides and therapeutic, diagnostic, or imaging agents.
本发明涉及树状分子与多个靶向肽以及一个或多个治疗、诊断或成像剂的共轭,用于将这些剂送达血脑屏障并进入特定细胞类型,包括表达LRP-1受体的细胞。还描述了制备包含树状分子与靶向肽和治疗、诊断或成像剂的化合物的方法。